0001209191-23-010050.txt : 20230216
0001209191-23-010050.hdr.sgml : 20230216
20230216161412
ACCESSION NUMBER: 0001209191-23-010050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230214
FILED AS OF DATE: 20230216
DATE AS OF CHANGE: 20230216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23638669
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-14
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2023-02-14
4
S
0
800
295.84
D
81203
D
Common Stock
2023-02-14
4
S
0
901
296.85
D
80302
D
Common Stock
2023-02-14
4
S
0
560
298.14
D
79742
D
Common Stock
2023-02-14
4
S
0
2003
299.13
D
77739
D
Common Stock
2023-02-14
4
S
0
1734
300.09
D
76005
D
Common Stock
2023-02-14
4
S
0
400
300.89
D
75605
D
Common Stock
140
I
401(k)
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $295.84 (range $295.34 to $296.20).
Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.49 to $297.30).
Open market sales reported on this line occurred at a weighted average price of $298.14 (range $297.59 to $298.57).
Open market sales reported on this line occurred at a weighted average price of $299.13 (range $298.68 to $299.60).
Open market sales reported on this line occurred at a weighted average price of $300.09 (range $299.73 to $300.70).
Open market sales reported on this line occurred at a weighted average price of $300.89 (range $300.78 to $301.03).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-02-16